250. IMPROVEMENTS IN QUALITY OF LIFE IN BEHÇET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. (29th March 2019)